Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Haifa
Clinical trial register · Israel

Clinical Trials in Haifa, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Israel and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2438 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2438
Studies in scope
all four open statuses
1243
Recruiting now
open to new participants
461
Lead sponsors
across recruiting studies
Top sites
Tel Aviv 28 Jerusalem 27 Petah Tikva 24 Ramat Gan 24 Haifa 22
Narrow the registerReset
Recruitment status
Phase
Site location
Tel Aviv28 Jerusalem27 Petah Tikva24 Ramat Gan24 Haifa22
All 18 locations
Target enrolment
to

Trials with a site in Haifa

22 of 2438 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Israel
Start
Recruiting
Hoffmann-La Roche
Phase 3
380
Haifa, Jerusalem, Ramat Gan, Tel Aviv
2026-06-23
Recruiting
Hoffmann-La Roche
Phase 3
600
Beersheba, Haifa, Jerusalem, Ramat Gan
2025-03-17
Active, closed
A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)
NCT06680817Neovascular Age-related Macular Degeneration, Diabetic Macular Edema
Hoffmann-La Roche
Observational
875
Ashkelon, Beer Jacob, Beersheba, Haifa, Jerusalem
2025-02-05
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Hoffmann-La Roche
Phase 3
1,800
Afula, Beersheba, Haifa, Jerusalem, Nahariya, Petah Tikva, Tel Aviv, Tel HaShomer
2024-05-24
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Hoffmann-La Roche
Phase 3
1,350
Afula, Beersheba, Haifa, Jerusalem, Nahariya, Petah Tikva, Ramat Gan, Tel Aviv
2024-03-13
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Ashdod, Ashkelon, Beersheba, Be’er Ya‘aqov, Haifa, Jerusalem, Kfar Saba, Petach Tiqwa
2023-06-28
Active, closed
Hoffmann-La Roche
Phase 3
1,290
Beersheba, Haifa, Jerusalem, Kfar Saba
2022-12-29
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
Hoffmann-La Roche
Observational
6,000
Haifa, Holon, Jerusalem, Kfar Saba, Petah Tikva, Tel Aviv
2022-11-21
Active, closed
Hoffmann-La Roche
Phase 3
83
Haifa, Petah Tikva, Ramat Gan
2021-10-22
Active, closed
Hoffmann-La Roche
Phase 3
451
Haifa, Jerusalem, Kfar Saba, Petah Tikva, Rehovot, Tel Aviv
2021-07-14
Recruiting
Hoffmann-La Roche
Phase 1/2
316
Jerusalem, Haifa, Petah Tikva, Ramat Gan, Tel Aviv
2021-06-22
Active, closed
Hoffmann-La Roche
Observational
800
Haifa, Petah Tikva, Ramat Gan, Tel Aviv
2021-05-10
Active, closed
Hoffmann-La Roche
Phase 3
557
Haifa, Petah Tikva, Tel Aviv
2021-04-26
Active, closed
Hoffmann-La Roche
Phase 1/2
518
Haifa, Jerusalem, Petah Tikva, Tel Aviv
2020-11-01
Active, closed
Hoffmann-La Roche
Phase 3
985
Haifa, Ramat Gan, Tel Aviv
2020-10-26
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Haifa, Jerusalem, Kfar Saba, Petah Tikva, Rehovot, Tel Aviv
2018-09-20
Active, closed
Hoffmann-La Roche
Phase 3
257
Haifa, Kfar Saba
2018-08-16
Recruiting
Hoffmann-La Roche
Phase 1/2
1,132
Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
2018-03-30
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Beersheba, Haifa, Kfar Saba, Petah Tikva, Ramat Gan, Tel Aviv
2017-09-22
Rows per page Showing 1–22 of 22
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Israeli investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-israel/city/haifa

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Israel and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,438 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 22 of those studies with a site in Haifa that also match the filters currently applied.

How many clinical trials are recruiting in Haifa?

9 of the 22 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 13 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Haifa), 22 studies
PhaseStudiesRecruitingShare
Phase 312554.5%
Phase 1/24318.2%
Observational3013.6%
Phase 2/3219.1%
Phase 1104.5%

Most active sponsors

Lead sponsors with the most studies (Haifa)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche229
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.